Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays
Standard
Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays. / Veličković, Vladica M; Rochau, Ursula; Conrads-Frank, Annette; Kee, Frank; Blankenberg, Stefan; Siebert, Uwe.
in: EXPERT REV PHARM OUT, Jahrgang 18, Nr. 6, 12.2018, S. 619-640.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays
AU - Veličković, Vladica M
AU - Rochau, Ursula
AU - Conrads-Frank, Annette
AU - Kee, Frank
AU - Blankenberg, Stefan
AU - Siebert, Uwe
PY - 2018/12
Y1 - 2018/12
N2 - INTRODUCTION: Despite the emphasis on the clinical importance of cardiac troponin assays (cTn), there are insufficient cost-effectiveness comparisons of various troponin test protocols for the diagnosis of myocardial infarction (MI). Therefore, the purpose of the review was to identify and systematically assess published economic evaluations using decision-analytic models for diagnostic testing strategies based on cTn and to make recommendations for the development of future models.AREAS COVERED: MEDLINE, Science Direct, Cochrane Database, CRD Database, and gray literature were screened for full economic evaluation studies with relevant clinical outcomes over a defined time horizon addressing a population with suspected MI and comparison of different diagnostic test strategies. Standardized forms for data extraction and evidence tables were used for the summary of study design, methodological framework and data sources. Studies were assessed for quality using the CHEERS and the BMJ checklists.EXPERT COMMENTARY: Although there are 11 identified studies and several well-designed models, there remains a need for decision-analytic models including differential diagnosis for acute MI, different health facility configurations, clinician preferences, and behavioral components, and in the top of the subgroup analyses additional important personalized medicine aspects.
AB - INTRODUCTION: Despite the emphasis on the clinical importance of cardiac troponin assays (cTn), there are insufficient cost-effectiveness comparisons of various troponin test protocols for the diagnosis of myocardial infarction (MI). Therefore, the purpose of the review was to identify and systematically assess published economic evaluations using decision-analytic models for diagnostic testing strategies based on cTn and to make recommendations for the development of future models.AREAS COVERED: MEDLINE, Science Direct, Cochrane Database, CRD Database, and gray literature were screened for full economic evaluation studies with relevant clinical outcomes over a defined time horizon addressing a population with suspected MI and comparison of different diagnostic test strategies. Standardized forms for data extraction and evidence tables were used for the summary of study design, methodological framework and data sources. Studies were assessed for quality using the CHEERS and the BMJ checklists.EXPERT COMMENTARY: Although there are 11 identified studies and several well-designed models, there remains a need for decision-analytic models including differential diagnosis for acute MI, different health facility configurations, clinician preferences, and behavioral components, and in the top of the subgroup analyses additional important personalized medicine aspects.
KW - Cost-Benefit Analysis
KW - Decision Support Techniques
KW - Diagnosis, Differential
KW - Diagnostic Tests, Routine/economics
KW - Humans
KW - Models, Economic
KW - Myocardial Infarction/diagnosis
KW - Troponin/analysis
U2 - 10.1080/14737167.2018.1512857
DO - 10.1080/14737167.2018.1512857
M3 - SCORING: Review article
C2 - 30115001
VL - 18
SP - 619
EP - 640
JO - EXPERT REV PHARM OUT
JF - EXPERT REV PHARM OUT
SN - 1473-7167
IS - 6
ER -